Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E Lenhard

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Cancer|September 24, 1999
The addition of interferon or high dose cyclophosphamide to standard chemotherapy in the treatment of patients with multiple myeloma: phase III Eastern Cooperative Oncology Group Clinical Trial EST 9486M M Oken, T Leong, R E Lenhard, et al.
Cancer|September 1, 1976
Combination chemotherapy of the malignant lymphomas: a controlled clinical trialR E Lenhard, R L Prentice, A H Owens, et al.
Cancer|January 15, 1980
Nodular mixed lymphocytic-histiocytic lymphoma (NM): response and survival. Eastern Cooperative Oncology GroupE Z Ezdinli, W G Costello, F Icli, et al.
Cancer|May 1, 1983
The influence of histologic subtype on toxicity and response to chemotherapy in non-hodgkin's lymphoma. An Eastern Cooperative Oncology Group Study utilizing the BCVP regimenM M Oken, W G Costello, G J Johnson, et al.
Cancer|November 1, 1993
The impact of clinical trial protocols on patient care systemsW Lawrence, K Antman, H P Freeman, et al.
Progress in Clinical and Biological Research|January 1, 1983
Patterns of care in oncology: an approach to medical and utilization auditW P Vaughan, T P Waalkes, R E Lenhard, et al.
Cancer|September 1, 1976
Comparison of intensive versus moderate chemotherapy of lymphocytic lymphomas: a progress reportE Ezdinli, S Pocock, C W Berard, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Cancer|September 24, 1999
The addition of interferon or high dose cyclophosphamide to standard chemotherapy in the treatment of patients with multiple myeloma: phase III Eastern Cooperative Oncology Group Clinical Trial EST 9486M M Oken, T Leong, R E Lenhard, et al.
Cancer|September 1, 1976
Combination chemotherapy of the malignant lymphomas: a controlled clinical trialR E Lenhard, R L Prentice, A H Owens, et al.
Cancer|January 15, 1980
Nodular mixed lymphocytic-histiocytic lymphoma (NM): response and survival. Eastern Cooperative Oncology GroupE Z Ezdinli, W G Costello, F Icli, et al.
Cancer|May 1, 1983
The influence of histologic subtype on toxicity and response to chemotherapy in non-hodgkin's lymphoma. An Eastern Cooperative Oncology Group Study utilizing the BCVP regimenM M Oken, W G Costello, G J Johnson, et al.
Cancer|November 1, 1993
The impact of clinical trial protocols on patient care systemsW Lawrence, K Antman, H P Freeman, et al.
Progress in Clinical and Biological Research|January 1, 1983
Patterns of care in oncology: an approach to medical and utilization auditW P Vaughan, T P Waalkes, R E Lenhard, et al.
Cancer|September 1, 1976
Comparison of intensive versus moderate chemotherapy of lymphocytic lymphomas: a progress reportE Ezdinli, S Pocock, C W Berard, et al.
Pageof 5